Skip to main content
Clinical Trials/NCT00466999
NCT00466999
Completed
Not Applicable

Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion

Gynuity Health Projects6 sites in 5 countries1,000 target enrollmentFebruary 2007

Overview

Phase
Not Applicable
Intervention
surgery
Conditions
Incomplete Abortion
Sponsor
Gynuity Health Projects
Enrollment
1000
Locations
6
Primary Endpoint
Complete abortion without recourse to surgical intervention.
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

In this study, we will compare the safety and efficacy of 400 mcg sublingually administered misoprostol alone to standard surgical care for the treatment of incomplete abortion. This study will provide important data on the role of misoprostol in health services offering an array of treatments for incomplete abortion. Women could significantly benefit from a non-invasive treatment option for incomplete abortion. While safe surgical services are becoming more widespread, there is still a serious risk of complications from these procedures. Especially in developing countries, infection, hemorrhage and uterine damage are still too common. Medical treatment of incomplete abortion using misoprostol would be a tremendous step to reducing morbidity and mortality due to abortion complications.

Registry
clinicaltrials.gov
Start Date
February 2007
End Date
November 2009
Last Updated
14 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Sponsor
Gynuity Health Projects
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Uterine size no larger than 12 weeks LMP at time of presentation for care.
  • Past or present history of vaginal bleeding during pregnancy.
  • Open cervical os.
  • If ultrasound used evidence of incomplete abortion with substantial debris in the uterus.
  • All women would have been advised to have surgical evacuation of the uterus if misoprostol was not available.
  • General good health.
  • Willing to provide contact information for purposes of follow-up.
  • Also in Egypt: 21 years of age or over or parental permission (there is no minimum age requirement in Niger, Mauritania and Senegal).

Exclusion Criteria

  • Contraindications to study drug
  • Signs of severe infection, defined as at least one of the following: 1) foul smelling discharge, 2) fever \> 38 degrees C , 3) uterine tenderness
  • Hemodynamic disturbances (pulse \>110/min and systolic bp \<100)
  • Have an IUD in place; (the IUD may be removed making the woman eligible)
  • Suspected ectopic pregnancy

Arms & Interventions

surgery

standard surgical treatment (either dilation and curettage or manual vacuum aspiration)

Intervention: surgery

misoprostol

400 mcg misoprostol

Intervention: misoprostol

Outcomes

Primary Outcomes

Complete abortion without recourse to surgical intervention.

Time Frame: follow up visit 7 days after initial treatment

Study Sites (6)

Loading locations...

Similar Trials